HomeOGN • NYSE
add
Organon & Co
Nakaraang pagsara
$16.00
Sakop ng araw
$15.75 - $16.10
Sakop ng taon
$13.87 - $23.10
Market cap
4.08B USD
Average na Volume
3.97M
P/E ratio
3.14
Dividend yield
7.07%
Primary exchange
NYSE
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 1.58B | 4.15% |
Gastos sa pagpapatakbo | 533.00M | -21.04% |
Net na kita | 359.00M | 518.97% |
Net profit margin | 22.69 | 493.98% |
Kita sa bawat share | 0.87 | 0.00% |
EBITDA | 459.00M | 56.66% |
Aktuwal na % ng binabayarang buwis | -73.43% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 763.00M | 84.30% |
Kabuuang asset | 12.75B | 15.80% |
Kabuuang sagutin | 12.26B | 5.67% |
Kabuuang equity | 493.00M | — |
Natitirang share | 257.54M | — |
Presyo para makapag-book | 8.38 | — |
Return on assets | 7.83% | — |
Return on capital | 10.81% | — |
Cash Flow
Net change in cash
| (USD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 359.00M | 518.97% |
Cash mula sa mga operasyon | 141.00M | -45.98% |
Cash mula sa pag-invest | -75.00M | -36.36% |
Cash mula sa financing | -78.00M | 0.00% |
Net change in cash | 59.00M | -32.95% |
Malayang cash flow | 29.00M | -85.07% |
Tungkol
Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy, and anesthesia. Organon produces all its products outside of the United States but gets a third of its revenue from the United States. Wikipedia
Itinatag
2020
Headquarters
Website
Mga Empleyado
10,000
